[EN] METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DE RECEPTEUR DE GLUTAMATE METABOTROPIQUE
申请人:LILLY CO ELI
公开号:WO2000069816A1
公开(公告)日:2000-11-23
This invention relates to a novel series of compounds which are useful in the treatment or prevention of a physiological disorder associated with an excess of stimulation of the human Group I metabotropic glutamate receptors, especially those designated as mGluR5. This invention also provides methods for the treatment of such disorders, as well as pharmaceutical formulations which employ the novel metabotropic glutamate receptor antagonists to which the present invention relates.
Catalytic Enantioselective Synthesis of Difluorinated Alkyl Bromides
作者:Mark D. Levin、John M. Ovian、Jacquelyne A. Read、Matthew S. Sigman、Eric N. Jacobsen
DOI:10.1021/jacs.0c07043
日期:2020.9.2
facilitated the development of an improved catalyst providing higher enantioselectivity with lower catalyst loadings. The versatility of the difluoroalkyl bromide products was demonstrated via highly enantiospecific substitution reactions with suitably reactive nucleophiles. The origins of enantioselectivity were investigated using computed interaction energies of simpli-fied catalyst and substrate structures